Understanding the link between prostate cancer treatment and metabolic dysfunction; promoting cancer screening in women; studying drug resistance in melanoma.
Jefferson activated participation in the clinical trial in just 14 days, reflecting the organization's commitment to making innovative therapies available to patients with serious and life-threatening conditions as quickly and safely as possible.
Predicting cardiac events in cancer patients with artificial intelligence; understanding limb apraxia; studying the link between stroke recovery and socioeconomic status.
